Pharma CEO, Daughter To Pay $2M In SEC Stock Fraud Case
By Sydney Price · July 2, 2026, 9:28 PM EDT
The Texas-based CEO of a purported pharmaceutical company and his daughter will pay nearly $2 million to end the U.S. Securities and Exchange Commission's claims accusing them and several others of...
To view the full article, register now.